- Home
- AVBP vs ADTN Comparison
AVBP vs ADTN Comparison
Compare AVBP & ADTN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AVBP
- ADTN
- Stock Information
- Founded
- AVBP 2021
- ADTN 1985
- Country
- AVBP United States
- ADTN United States
- Employees
- AVBP N/A
- ADTN N/A
- Industry
- AVBP
- ADTN Telecommunications Equipment
- Sector
- AVBP
- ADTN Telecommunications
- Exchange
- AVBP NYSE
- ADTN Nasdaq
- Market Cap
- AVBP 705.8M
- ADTN 616.5M
- IPO Year
- AVBP 2024
- ADTN 1994
- Fundamental
- Price
- AVBP $21.25
- ADTN $8.03
- Analyst Decision
- AVBP Strong Buy
- ADTN Strong Buy
- Analyst Count
- AVBP 7
- ADTN 4
- Target Price
- AVBP $39.29
- ADTN $12.00
- AVG Volume (30 Days)
- AVBP 234.7K
- ADTN 888.9K
- Earning Date
- AVBP 05-12-2025
- ADTN 05-07-2025
- Dividend Yield
- AVBP N/A
- ADTN N/A
- EPS Growth
- AVBP N/A
- ADTN N/A
- EPS
- AVBP N/A
- ADTN N/A
- Revenue
- AVBP N/A
- ADTN $944,291,000.00
- Revenue This Year
- AVBP $63.13
- ADTN $13.90
- Revenue Next Year
- AVBP N/A
- ADTN $9.13
- P/E Ratio
- AVBP N/A
- ADTN N/A
- Revenue Growth
- AVBP N/A
- ADTN N/A
- 52 Week Low
- AVBP $15.47
- ADTN $4.62
- 52 Week High
- AVBP $36.37
- ADTN $12.44
- Technical
- Relative Strength Index (RSI)
- AVBP 59.18
- ADTN 49.80
- Support Level
- AVBP $19.80
- ADTN $7.65
- Resistance Level
- AVBP $20.86
- ADTN $8.24
- Average True Range (ATR)
- AVBP 1.18
- ADTN 0.27
- MACD
- AVBP 0.12
- ADTN 0.02
- Stochastic Oscillator
- AVBP 88.39
- ADTN 37.62
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.
About ADTN ADTRAN Holdings Inc.
Adtran Holdings Inc is a provider of networking and communications platforms, software, and services focused on the broadband access market. It operates under two reportable segments: Network Solutions, which includes hardware and software products that enable a digital future that supports the company's Subscriber, Access & Aggregation, and Optical Networking Solutions; and Services & Support Segment which includes network design, implementation, maintenance and cloud-hosted services supporting the company's Subscriber, Access & Aggregation, and Optical Networking Solutions.